HMGB1 and neoplasm: This process involves the exposure of calreticulin (CRT) on the tumor cell surface, as well as the release of high mobility group box 1 (HMGB1) or adenosine triphosphate (ATP), which attract dendritic cells (DCs) for phagocytosis and antigen presentation16.